The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Stratified Randomization for Clinical Trials
Open accessAbstract
Trialists argue about the usefulness of stratified randomization. For investigators designing trials and readers who use them, the argument has created uncertainty regarding the importance of stratification. In this paper, we review stratified randomization to summarize its purpose, indications, accomplishments, and alternatives. In order to identify research papers, we performed a Medline search for 1966-1997. The search yielded 33 articles that included original research on stratification or included stratification as the major focus. Additional resources included textbooks. Stratified randomization prevents imbalance between treatment groups for known factors that influence prognosis or treatment responsiveness. As a result, stratification may prevent type I error and improve power for small trials (<400 patients), but only when the stratification factors have a large effect on prognosis. Stratification has an important effect on sample size for active control equivalence trials, but not for superiority trials. Theoretical benefits include facilitation of subgroup analysis and interim analysis. The maximum desirable number of strata is unknown, but experts argue for keeping it small. Stratified randomization is important only for small trials in which treatment outcome may be affected by known clinical factors that have a large effect on prognosis, large trials when interim analyses are planned with small numbers of patients, and trials designed to show the equivalence of two therapies. Once the decision to stratify is made, investigators need to chose factors carefully and account for them in the analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Yet, it does not control for imbalances between subgroups of baseline factors other than the treatment.”
From Understanding of interaction (subgroup) analysis in clinical trials (2019) · cites this paper as [34]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the comparison of treatment arms for the primary and secondary aims, we will use logistic regression models. Models will adjust for the three stratification factors as well as baseline factors that are significantly related to the outcome.64,65”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Additionally, each model considered baseline factors differing between treatment arms and associated with the outcome [73], preserving statistical power and ensuring precise 95% confidence intervals [74].”
From Can an Acceptance and Commitment Therapy-Based Smartphone App Help Individuals with Mental Health Disorders Quit Smoking? (2024) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Because pain severity is a factor that could affect outcomes and/or responsiveness to intervention [27], we stratified to avoid misattributing effects of the intervention (i.e., type 1 error), which is especially important in small trials [28].”
In the citing paper
“Stratified randomization only helps to obtain comparable numbers of participants in both treatment arms within each subgroup.34”
From Understanding of interaction (subgroup) analysis in clinical trials (2019) · cites this paper as [34]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930 · cited 4×
“Of greater importance is that it can improve statistical efficiency by making it more likely that equal numbers of patients are assigned to each treatment [7,9].”
BackgroundInfluentialPocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350 · cited 3×
“Minimization uses information about patients who are already in a trial to influence treatment assignment for new patients in such a way that differences between treatment groups are minimized [8,31,35].”
BackgroundMethodPeto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Fundamentals of Clinical Trials
Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015) · doi:10.1007/978-3-319-18539-2 · Cited by 2,237
Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014 · cited 4×
“In addition to setting an appropriate P value, another principle of execution is to identify subgroups before the trial is started [26,27].”
BackgroundInfluentialA consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914
Minimization: A new method of assigning patients to treatment and control groups
Taves, D. R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974155443 · Cited by 891 · cited 1×
“Minimization uses information about patients who are already in a trial to influence treatment assignment for new patients in such a way that differences between treatment groups are minimized [8,31,35].”
BackgroundThe randomization and stratification of patients to clinical trials
Zelen, M. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90015-0 · Cited by 613 · cited 2×
“In simple (or complete) randomization [9–11], investigators make up a single randomization list before the trial is begun.”
Background
Cited by
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
“Stratification has been shown to increase the power of small randomized trials by up to 12%, especially in the presence of a large intervention effect or strong prognostic stratifying variables (109).”
BackgroundIn Pursuit of Balance: Randomization in Practice in Development Field Experiments
Bruhn, M., & McKenzie, D. (2009) · American Economic Journal: Applied Economics · doi:10.1257/app.1.4.200 · Cited by 788
“…as stratification, matching, and minimization claim that such methods can improve efficiency, increase power, and protect against type I errors (Kernan et al., 1999) and do not seem to have significant disadvantages, except in small samples (Imai et al. 2008, Greevy et al. 2004, Aickin, 2001)2.”
InfluentialThe method of minimization for allocation to clinical trials
Scott, N. W., McPherson, G. C., Ramsay, C. R., & Campbell, M. K. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00242-8 · Cited by 651
National Cluster-Randomized Trial of Duty-Hour Flexibility in Surgical Training
Bilimoria, K. Y., Chung, J. W., Hedges, L. V., Dahlke, A. R., Love, R., Cohen, M. E., Hoyt, D. B., Yang, A. D., Tarpley, J. L., Mellinger, J. D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515724 · Cited by 460
Metadata
- Authors
- Kernan, W. N., Viscoli, C. M., Makuch, R. W., Brass, L. M., & Horwitz, R. I.
- Affiliations
- Yale University (US)
- Corresponding author
- Kernan, Walter N.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 52
- Issue
- 1
- Pages
- 19-26
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2012796013
- Cited by
- 627
- References
- 42
- Citations by year
- 2026: 36 · 2025: 52 · 2024: 47 · 2023: 52 · 2022: 42 · 2021: 31 · 2020: 39 · 2019: 31 · 2018: 44 · 2017: 30 · 2016: 29 · 2015: 24 · 2014: 26 · 2013: 25 · 2012: 18
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 385 d)
- Locations
- Journal of Clinical Epidemiology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (1-R01-N531251-03)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- stratified randomization, clinical trial design, type I error, statistical power, small trials, sample size, equivalence trials, subgroup analysis, interim analysis, prognostic factors
- MeSH terms
- Data Interpretation, Statistical, Humans, Prognosis, Random Allocation, Research Design, Reproducibility of Results, Bias, Effect Modifier, Epidemiologic, Randomized Controlled Trials as Topic, Treatment Outcome, Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stratified Randomization for Clinical Trials. https://app.cochat.ai/papers/10.1016/s0895-4356(98)00138-3
- The paper
- Kernan, W. N., Viscoli, C. M., Makuch, R. W., Brass, L. M., & Horwitz, R. I. (1999). Stratified Randomization for Clinical Trials. Journal of Clinical Epidemiology. https://doi.org/10.1016/s0895-4356(98)00138-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.